ReviewActa pharmaceutica Sinica. B2026

Drugging non-canonical kinases in cancer therapeutics: Molecular targets, underlying mechanisms and small-molecule inhibitors.

Xuelan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.